Notwithstanding the lack of good quality analyst coverage, what will mitigate the company's credibility for certain is for Resverlogix's management to pull up their socks and get going with the Covid 19 clinical trial to provide definitive proof that ABL has what it takes to get the job done. As they say, that the proof is in the pudding. 

Don, please get something done before the SPP gets to a point of no return. Any deal right now is better than a no deal at all.  The market needs to know that there is something viable going on behind closed doors in Calgary. 

Don we need to see the pudding and enough with the theoretical and the theatrics, please.

Koo